Marpai, Inc. has officially filed its annual report, shedding light on its financial performance and strategic direction as of December 31, 2025. This filing is significant as it provides stakeholders with a comprehensive overview of the company's operations, achievements, and future plans.

Background

Marpai, Inc., classified under the SIC code 8090, operates in the Services-Misc Health & Allied Services, NEC sector. The company is listed on the OTC exchange under the ticker symbol MRAI. As a smaller reporting company and an emerging growth entity, Marpai continues to focus on delivering innovative health services.

What the Filing Says

The filing, dated November 9, 2026, does not provide detailed financial metrics or specific operational highlights. However, it indicates that the company is committed to transparency and regulatory compliance, which is crucial for maintaining investor confidence.

Impact

This filing may impact various stakeholders, including investors, analysts, and competitors within the health services industry. By sharing its annual performance, Marpai allows others in the sector to benchmark their own strategies and outcomes against its results.

What's Next

Following this filing, Marpai is expected to continue its reporting cycle, with its next quarterly report anticipated on November 12, 2026. This will provide further insights into its financial health and operational progress.

Source: SEC Accession Number 0001213900-26-117609